274 related articles for article (PubMed ID: 27746879)
1. Rare Aggressive Behavior of
Ben Salha I; Zaidi S; Noujaim J; Miah AB; Fisher C; Jones RL; Thway K
Rare Tumors; 2016 Sep; 8(3):6282. PubMed ID: 27746879
[TBL] [Abstract][Full Text] [Related]
2. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
3. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated liposarcoma with lipoma-like well-differentiated liposarcoma: clinicopathological study of 30 cases, with particular attention to the comingling pattern of well- and dedifferentiated components: a proposal for regrouping of the present subclassification of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Iwasa Y; Nakashima Y
Int J Surg Pathol; 2013 Feb; 21(1):15-21. PubMed ID: 22674916
[TBL] [Abstract][Full Text] [Related]
7. p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics.
Kang Y; Horvai AE
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):58-63. PubMed ID: 26509911
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
9. Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation.
Huang HY; Brennan MF; Singer S; Antonescu CR
Mod Pathol; 2005 Jul; 18(7):976-84. PubMed ID: 15832195
[TBL] [Abstract][Full Text] [Related]
10. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
11. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
Song MJ; Cho KJ; Lee JS; Song JS
Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
McCormick D; Mentzel T; Beham A; Fletcher CD
Am J Surg Pathol; 1994 Dec; 18(12):1213-23. PubMed ID: 7977944
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated liposarcoma with heterologous spindle cell rhabdomyoblastic de-differentiation: An unusual pattern expanding the morphological spectrum.
Rekhi B; Baheti AD; Patkar S
Indian J Pathol Microbiol; 2020; 63(4):630-633. PubMed ID: 33154322
[TBL] [Abstract][Full Text] [Related]
15. Biology and Management of Dedifferentiated Liposarcoma: State of the Art and Perspectives.
Nishio J; Nakayama S; Nabeshima K; Yamamoto T
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362013
[TBL] [Abstract][Full Text] [Related]
16. Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases.
Lokka S; Scheel AH; Dango S; Schmitz K; Hesterberg R; Rüschoff J; Schildhaus HU
BMC Clin Pathol; 2014; 14():36. PubMed ID: 25126005
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
18. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
19. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
Thway K; Wang J; Swansbury J; Min T; Fisher C
Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
